ImmunityBio Class Action Lawsuit Claims Investors Were Misled About Cancer Drug Approval Risks

Yes, investors in ImmunityBio are claiming they were misled about the approval and efficacy of the company's cancer drug ANKTIVA.
Filing claims and class action participation

Yes, investors in ImmunityBio are claiming they were misled about the approval and efficacy of the company's cancer drug ANKTIVA.

Driven Brands Holdings Inc. concealed significant accounting errors and internal control failures from investors, leading to a major securities fraud...

Vital Farms, Inc. faces a class action lawsuit alleging that the company and its senior executives made materially false and misleading statements about a...

monday.com Ltd., a publicly traded work management software company trading on NASDAQ under the ticker MNDY, faces a federal class action lawsuit alleging...

Yes, ChampionX investors are claiming they were misled about material information during a critical period when company executives were repurchasing...

Kalshi, a federally regulated prediction market platform, faces mounting class action lawsuits across multiple states claiming that its betting mechanics...

A False Claims Act lawsuit is a civil claim filed against a person or company that has defrauded the federal government by submitting false bills, making...

The statute of limitations for mass tort claims typically ranges from two to four years in most states, though deadlines can extend from as short as one...

If you're looking to file a claim in the 3M earplug lawsuit, the direct answer is that you likely cannot""the registration deadline has passed, and the...

For those who did file before the deadline, the process is far from over. Consider a veteran who submitted a claim in early 2024: if the Navy denied that...